1. 1) Lycke J, Tollesson PO, Frisén L. Asymptomatic visual loss in multiple sclerosis. J. Neurol., 248, 1079–1086 (2001).
2. 2) Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol., 24, 83–97 (2014).
3. 3) Arnold AC. Evolving management of optic neuritis and multiple sclerosis. Am. J. Ophthalmol., 139, 1101–1108 (2005).
4. 4) Beck RW, Gal RL, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, Kaufman DI, Keltner JL, Kupersmith MJ, Miller NR, Moke PS, Nazarian S, Orengo-Nania S, Savino PJ, Shults WT, Smith CH, Trobe JD, Wall M, Xing D, Optic Neuritis Study Group. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am. J. Ophthalmol., 137, 77–83 (2004).
5. 5) Bennett JL, Nickerson M, Costello F, Sergott RC, Calkwood JC, Galetta SL, Balcer LJ, Markowitz CE, Vartanian T, Morrow M, Moster ML, Taylor AW, Pace TW, Frohman T, Frohman EM. Re-evaluating the treatment of acute optic neuritis. J. Neurol. Neurosurg. Psychiatry, 86, 799–808 (2015).